These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16298725)

  • 41. Exposure to novel environmental stimuli decreases amphetamine self-administration in rats.
    Klebaur JE; Phillips SB; Kelly TH; Bardo MT
    Exp Clin Psychopharmacol; 2001 Nov; 9(4):372-9. PubMed ID: 11764013
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A cost-effectiveness evaluation of single and combined smoking cessation interventions in Texas.
    Hill A
    Tex Med; 2006 Aug; 102(8):50-5. PubMed ID: 17115560
    [No Abstract]   [Full Text] [Related]  

  • 43. Effects of nicotine withdrawal on performance under a progressive-ratio schedule of sucrose pellet delivery in rats.
    LeSage MG; Burroughs D; Pentel PR
    Pharmacol Biochem Behav; 2006 Apr; 83(4):585-91. PubMed ID: 16643998
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toward a nonhuman model of contingency management: effects of reinforcing abstinence from nicotine self-administration in rats with an alternative nondrug reinforcer.
    Lesage MG
    Psychopharmacology (Berl); 2009 Mar; 203(1):13-22. PubMed ID: 18946663
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histamine H(1) antagonist treatment with pyrilamine reduces nicotine self-administration in rats.
    Levin ED; Slade S; Wells C; Pruitt M; Cousins V; Cauley M; Petro A; Hampton D; Rose J
    Eur J Pharmacol; 2011 Jan; 650(1):256-60. PubMed ID: 20951696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Individual differences in responding to bupropion or varenicline in a preclinical model of nicotine self-administration vary according to individual demand for nicotine.
    Kazan T; Charntikov S
    Neuropharmacology; 2019 Apr; 148():139-150. PubMed ID: 30611697
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bupropion-varenicline interactions and nicotine self-administration behavior in rats.
    Hall BJ; Slade S; Wells C; Rose JE; Levin ED
    Pharmacol Biochem Behav; 2015 Mar; 130():84-9. PubMed ID: 25616031
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of chronic treatment with bupropion on self-administration of nicotine + cocaine mixtures in nonhuman primates.
    de Moura FB; Barkin CE; Blough BE; Carroll FI; Mello NK; Kohut SJ
    Exp Clin Psychopharmacol; 2020 Oct; 28(5):517-526. PubMed ID: 31789555
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Using growth models to relate acquisition of nicotine self-administration to break point and nicotinic receptor binding.
    Donny EC; Lanza ST; Balster RL; Collins LM; Caggiula A; Rowell PP
    Drug Alcohol Depend; 2004 Jul; 75(1):23-35. PubMed ID: 15225886
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of individual differences in response to acute bupropion or varenicline treatment using a long-access nicotine self-administration model and behavioral economics in female rats.
    Kazan T; Robison CL; Cova N; Madore VM; Charntikov S
    Behav Brain Res; 2020 May; 385():112558. PubMed ID: 32109437
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of N-acetylcysteine or bupropion on methamphetamine self-administration and methamphetamine-triggered reinstatement of female rats.
    Charntikov S; Pittenger ST; Pudiak CM; Bevins RA
    Neuropharmacology; 2018 Jun; 135():487-495. PubMed ID: 29604294
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat.
    Cryan JF; Bruijnzeel AW; Skjei KL; Markou A
    Psychopharmacology (Berl); 2003 Jul; 168(3):347-58. PubMed ID: 12698231
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nornicotine pretreatment decreases intravenous nicotine self-administration in rats.
    Green TA; Phillips SB; Crooks PA; Dwoskin LP; Bardo MT
    Psychopharmacology (Berl); 2000 Oct; 152(3):289-94. PubMed ID: 11105939
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Smoking cessation--part III: Pharmacotherapy of smoking cessation.
    Wilken L; Corbridge SJ
    AAOHN J; 2005 Aug; 53(8):340-4. PubMed ID: 16122137
    [No Abstract]   [Full Text] [Related]  

  • 55. Bupropion differentially impacts acquisition of methamphetamine self-administration and sucrose-maintained behavior.
    Reichel CM; Linkugel JD; Bevins RA
    Pharmacol Biochem Behav; 2008 May; 89(3):463-72. PubMed ID: 18329085
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Neuropsychopharmacological profile of nicotine].
    Ando K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Apr; 24(2):55-9. PubMed ID: 15164610
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An investigation of bupropion substitution for the interoceptive stimulus effects of nicotine.
    Wilkinson JL; Carroll FI; Bevins RA
    J Psychopharmacol; 2010 Jun; 24(6):817-28. PubMed ID: 19304864
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lobelane decreases methamphetamine self-administration in rats.
    Neugebauer NM; Harrod SB; Stairs DJ; Crooks PA; Dwoskin LP; Bardo MT
    Eur J Pharmacol; 2007 Sep; 571(1):33-8. PubMed ID: 17612524
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bupropion attenuates methamphetamine self-administration in adult male rats.
    Reichel CM; Murray JE; Grant KM; Bevins RA
    Drug Alcohol Depend; 2009 Feb; 100(1-2):54-62. PubMed ID: 19010609
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Experimenter administered Δ
    Abraham AD; Wiley JL; Marusich JA
    Pharmacol Biochem Behav; 2023 Oct; 231():173632. PubMed ID: 37690617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.